Choose License Type
The global clinical trial support services market is categorized based on phase, and service type. In 2019, North America dominated the global clinical trial support services market owing to the presence of large pharmaceutical companies operating across the United States. Growing R&D investments and increasing demand for drug production are both taking place, which are the key reasons for the growth of the overall market. Also, clinical trial site management providers for the management of offshore operations have undergone significant growth due to the rise in clinical trial outsourcing.
The emergence of COBID-19 is anticipated to boost demand for the clinical trial support services market over the forecast period. The majority of the firms and businesses around the world are threatened by the quickly emerging danger due to the outbreak of COVID-19. The pandemic has also adversely affected the current drug trial ecosystem. For multiple therapeutic areas, it has influenced several ongoing trials. However, to resolve this, researchers are working to create novel therapeutics which is anticipated to fuel clinical trial support services market growth over the forecast period.
The presence of pharmaceutical and biotechnology giants across the United States and Europe has led to outsourcing the clinical trials facility to emerging economies for the development of new and innovative drugs. Asia Pacific region remains to be one of the preferred destinations for outsourcing clinical trials. Also, the Asia Pacific region offers a lucrative opportunity for clinical trial support services owing to advantages such as a large patient pool, low recruitment time of human subjects, and cost-effectiveness among others. The urban population across the globe stands to 3.9 billion in 2015 from 746 million in 1950, which is again expected to reach approximately 5 billion by the end of 2030. Asia Pacific region holds the maximum percentage of the urban population i.e. 53%. The growth of such a population will leverage a wide opportunity for clinical trial support services industries as it would reduce the overall cost in the recruitment of human subjects and thus fasten the enrolment process.
Key segments of the global clinical trial support services market
Phase Overview, 2018-2028 (USD Million)
Service Type Overview, 2018-2028 (USD Million)
Regional Overview, 2018-2028 (USD Million)
Important Companies in Global Clinical Trial Support Services Market
Reasons for the study
What does the report include?
Who should buy this report?
The global clinical trial support services market is categorized based on phase, and service type. In 2019, North America dominated the global clinical trial support services market owing to the presence of large pharmaceutical companies operating across the United States. Growing R&D investments and increasing demand for drug production are both taking place, which are the key reasons for the growth of the overall market. Also, clinical trial site management providers for the management of offshore operations have undergone significant growth due to the rise in clinical trial outsourcing.
The emergence of COBID-19 is anticipated to boost demand for the clinical trial support services market over the forecast period. The majority of the firms and businesses around the world are threatened by the quickly emerging danger due to the outbreak of COVID-19. The pandemic has also adversely affected the current drug trial ecosystem. For multiple therapeutic areas, it has influenced several ongoing trials. However, to resolve this, researchers are working to create novel therapeutics which is anticipated to fuel clinical trial support services market growth over the forecast period.
The presence of pharmaceutical and biotechnology giants across the United States and Europe has led to outsourcing the clinical trials facility to emerging economies for the development of new and innovative drugs. Asia Pacific region remains to be one of the preferred destinations for outsourcing clinical trials. Also, the Asia Pacific region offers a lucrative opportunity for clinical trial support services owing to advantages such as a large patient pool, low recruitment time of human subjects, and cost-effectiveness among others. The urban population across the globe stands to 3.9 billion in 2015 from 746 million in 1950, which is again expected to reach approximately 5 billion by the end of 2030. Asia Pacific region holds the maximum percentage of the urban population i.e. 53%. The growth of such a population will leverage a wide opportunity for clinical trial support services industries as it would reduce the overall cost in the recruitment of human subjects and thus fasten the enrolment process.
Key segments of the global clinical trial support services market
Phase Overview, 2018-2028 (USD Million)
Service Type Overview, 2018-2028 (USD Million)
Regional Overview, 2018-2028 (USD Million)
Important Companies in Global Clinical Trial Support Services Market
Reasons for the study
What does the report include?
Who should buy this report?
Chapter 1. Introduction
1.1. Introduction to the Study
1.2. Market Definition and Scope
1.3. Units, Currency, Conversions and Years Considered
1.4. Key Stakeholders
1.5. Key Questions Answered
Chapter 2. Research Methodology
2.1. Introduction
2.2. Data Capture Sources
2.3. Primary Sources
2.4. Secondary Sources
2.5. Market Size Estimation
2.6. Market Forecast
2.7. Data Triangulation
2.8. Assumptions and Limitations
Chapter 3. Market Outlook
3.1. Introduction
3.2. Macroeconomic Indicators
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities
3.3.4. Challenges
3.4. Porter’s Five Forces Analysis
3.5. PESTLE Analysis
3.6. COVID-19 Impact Analysis
Chapter 4. Global Clinical Trial Support Services Market by Phase, 2018-2028 (USD Million)
4.1.1. Phase I
4.1.2. Phase II
4.1.3. Phase III
4.1.4. Phase IV
Chapter 5. Global Clinical Trial Support Services Market by Service Type, 2018-2028 (USD Million)
5.1.1. Clinical Trial Site Management
5.1.2. Patient Recruitment Management
5.1.3. Assay Development
5.1.4. Contract Manufacturing
5.1.5. Packaging, Storage and Distribution Services
5.1.6. Commercialization
5.1.7. Other Service Types
Chapter 6. Global Clinical Trial Support Services Market by Region, 2018-2028 (USD Million)
6.1. North America
6.1.1. U.S.
6.1.2. Canada
6.2. Europe
6.2.1. Germany
6.2.2. UK
6.2.3. France
6.2.4. Spain
6.2.5. Rest of Europe
6.3. Asia Pacific
6.3.1. Japan
6.3.2. China
6.3.3. India
6.3.4. Rest of Asia Pacific
6.4. South America
6.4.1. Brazil
6.4.2. Mexico
6.4.3. Rest of South America
6.5. Middle East and Africa
6.5.1. GCC
6.5.2. South Africa
6.5.3. Rest of Middle East and Africa
Chapter 7. Competitive Landscape
7.1. Company Positioning
7.2. Strategic Initiatives
7.2.1. Mergers & Acquisitions
7.2.2. New Product Launch
7.2.3. Investments
7.2.4. Expansion
7.2.5. Others
Chapter 8. Company Profiles
8.1. Charles River Laboratories, Inc.
8.2. Eurofins Scientific
8.3. Laboratory Corporation of America Holdings (Covance Inc.)
8.4. WuXi AppTec
8.5. Insight Genetics
8.6. PPD Inc.
8.7. Alcura Health
8.8. Parexel International
8.9. Icon PLC
8.10. IQVIA
Chapter 9. Appendix
9.1. Primary Research Approach
9.1.1. Primary Interview Participants
9.1.2. Primary Interview Summary
9.2. Questionnaire
9.3. Related Reports
9.3.1. Published
9.3.2. Upcoming